Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Table base
Active pulse blood constituent monitoring
Detecting mirrors on the web
Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
Aqueous composition with agents to inhibit water evaporation
Pet carrier
Digital display devices and digital projectors with expanded color gamut
  Randomly Featured Patents
Reduced flicker AC LED lamp with separately shortable sections of an LED string
System and method for performing predicated selection of an output register
Semiconductor device and manufacturing method thereof
Method of sealing the ends of an elastomeric roll
Aspheric spectacle lens blank
Inbred maize line PHTP9
Mixing valve assembly
Process for the manufacture of self-crosslinking paint binders
Biological sludge-energy recycling method
Piston for two cycle engine